Bridging advanced diagnostic and AI technologies with concierge telemedicine services for compassionate use patients.
Imagine these scenarios
Your Father
Your father has stage 4 lung cancer. His tumor has become resistant to the last available approved therapy, and his doctors inform him that he’s not eligible for any promising clinical trials. They estimate he has just three months to live. How far would you go to find a way to save his life?
Your Daughter
Your three-month-old daughter has been diagnosed with a rare genetic disease for which there is no known cure or therapy. The doctors are uncertain about the exact diagnosis, leaving you with more questions than answers. What would you do to find hope and a solution for her?
BRIDGES of COMPASSION Has the Solution
Compassionate care patients, are patients who have exhausted all standard treatment options for potentially life-threatening diseases and are left with little to no hope.
- The number of patients who fall into this category is staggering:
Cancer: it is estimated that in the US alone around 400,000-600,000 patients each year will become eligible for compassionate use. - Rare genetic diseases: the number of patients where there is no approved therapies has been estimated to be close to 200 million patients worldwide.
BRIDGES of COMPASSION offers these patients renewed hope through an innovative approach that combines advanced diagnostic tools, AI technologies, and a telehealth platform. Our solution provides comprehensive patient support while reducing the administrative burden on physicians.
By following the patient’s journey, our platform ensures that each individual receives the best available treatment options, guided by proprietary diagnostics and AI-driven insights. At the same time, we gather valuable feedback from patients, which continually enhances the algorithm and its effectiveness.
Elite Team Behind
BRIDGES of COMPASSION
The Company was founded by two innovators and venture builders:
Ascher Shmulewitz and Asher Nathan. Bridges of Compassion has assembled an impressive team of experienced and successful industry experts, that includes a Nobel Laureate, former pharmaceutical executives, go-to-market strategists, an insurance leader, and a former Chief Investment Officer of one of the largest restructuring deals in US history. We are currently raising our series A investment.
Join Us in Transforming Medicine
Work for us:
Highly motivated individuals who truly want to change the world and the way medicine is practiced and who want to work in a challenging yet fun environment. We are looking for individuals with relevant diagnostic, medical AI and telehealth experience.
Work with us:
Looking for pharmaceutical companies who would consider utilizing their new clinical stage experimental medications in an AI selected patient population.
Let us help you
Physicians that are truly interested in benefiting their patients and are interested in participating in this one-of-a kind pilot program open for oncology patients and patients with rare genetic disease
Patients contact us if you are out of options and want to learn more.